doi: 10.1016/j.anifeedsci.2020.114595 106 RebeloL
Identification of Novel AR-Targeted MicroRNAs mediating androgen signalling through critical pathways to regulate cell viability in prostate cancer
Interestingly, glucagon-like peptide-1 receptor agonists (GLP-1RAs), used in the treatment of T2DM and obesity, are known to show pro-cognitive and neuroprotective properties, and exert modulatory effects on immune, endocrine and metabolic processes in the central nervous system
A retrospective analysis of patients on semaglutide or liraglutide found that 12.7% developed at least one nutritional deficiency within six months of starting therapy
All dosages of danuglipron significantly reduced patients HbA1c and fasting blood glucose levels, with more pronounced weight loss effects observed in the 80 mg and 120 mg doses compared to the placebo group
Participants were assigned to: GLP-1 medication (liraglutide) CPAP therapy (a breathing machine for sleep apnea) Both GLP-1 + CPAP Special PET-CT scans measured how active each persons visceral fat was in other words, how much energy it was burning